Building the Digital Foundation for Process Intensification
Rising cost pressures and biosimilar competition require manufacturers to maximize bioprocess productivity. At the same time, the increasing emphasis on sustainability and lean manufacturing initiatives is driving the need for greater efficiency and reduced facility footprints.
Process Intensification Is No Longer Optional
Process intensification provides the foundation to deliver these outcomes, offering a clear path toward higher productivity, lower cost of goods, and reduced environmental impact.
Intensification strategies are increasingly well-established in upstream processes, achieving higher titers in monoclonal antibody production. However, these incremental advances have created new operational complexities and downstream bottlenecks. To fully leverage the benefits of intensified processing, automated continuous biomanufacturing becomes the logical end goal.
Without a strong digital infrastructure and supporting analytics, process complexity can quickly outweigh the benefits of intensification.
Complexity in Intensified Processes: Why Traditional Automation Falls Short
While the benefits of process intensification are clear, its implementation introduces significant operational hurdles that challenge conventional automation strategies.
Coordination
In intensified manufacturing, upstream and downstream operations are often decoupled from the traditional batch rhythm. Continuous perfusion bioreactors may run for weeks, while downstream steps follow independent timelines.
Poor synchronization between these steps necessitates manual handoffs, increasing the risk of process deviations and undermining the efficiency gains of continuous processing.
Control
Intensified processes operate within narrow control windows. There is limited time to detect and correct deviations, and even small disturbances can significantly impact outcomes. The large number of interdependent variables makes reliance on offline, single-point measurements insufficient.
Integration
In many facilities, upstream and downstream equipment is sourced from multiple vendors. This creates fragmentation across the process, leading to complex custom integrations and challenging automation strategies.
These realities push traditional automation and analytics approaches beyond their limits. A cohesive digital architecture is essential for implementing and scaling intensified processes successfully.
The Digital Foundation for Intensification
Process intensification requires a robust, intelligent digital infrastructure that spans local equipment control, cross-unit orchestration, and advanced analytics to enable real-time decision-making, from process development to commercial manufacturing.
To address this need, Sartorius has developed a modular, integration-ready digital ecosystem designed specifically for biopharmaceutical manufacturing.
At the heart of this ecosystem is the Biobrain® architecture, which provides a layered digital framework — Control, Supervise, and Operate — enabling stepwise digital transformation. Biobrain® is complemented by the Umetrics® Digital Twin AI Ecosystem, delivering advanced analytics for building bioprocess digital twins using experimental design, mechanistic models, and | or machine learning.
Equipment-Level Automation — Biobrain® Control
The Biobrain® Control layer delivers real-time automation for individual unit operations. It can function autonomously or integrate seamlessly with distributed control systems, providing precise parameter control across both batch and continuous biomanufacturing environments.
Centralized Orchestration — Biobrain® Supervise and Biobrain® Operate
The Biobrain® Supervise layer aggregates data across equipment and systems, including multi-vendor setups, enabling centralized monitoring and performance visualization across the process. Reliable data acquisition and historization ensure traceability and audit-ready documentation.
Biobrain® Supervise also provides comprehensive process orchestration capabilities tailored to intensified processing: built-in rule sets keep connected operations synchronized, reducing engineering effort and minimizing risk.
Biobrain® Operate complements the Supervise layer by orchestrating human activity across the workflow. It delivers dynamic, step-by-step operator guidance to ensure consistent process execution — critical in intensified environments where small deviations can have large impacts. Real-time data capture through electronic batch records streamlines review processes and supports regulatory compliance.
Advanced Analytics & Digital Twins — Umetrics® Digital Twin AI Ecosystem
The Umetrics® Digital Twin AI Ecosystem provides the data intelligence required for predictive control, process optimization, and early deviation detection — all essential in the fast-paced environment of intensified processing, where small variabilities can have significant downstream impacts.
Through multivariate data analysis (MVDA), machine learning models, and soft sensors, Umetrics® Digital Twin AI Ecosystem allows users to:
- Build predictive bioprocess digital twin models based on real process dynamics
- Optimize processes in real time
- Detect deviations before thresholds are exceeded
- Monitor product quality trends across batches or campaigns
- Execute real-time release strategies
From Reactive to Predictive to Autonomous: The Road to Biomanufacturing 4.0
As digital transformation in biopharma advances, solutions will move from supporting process intensification to driving autonomous and self-optimizing operations, a defining characteristic of Biomanufacturing 4.0.
This progression includes:
- Real-time release – Real-time monitoring of critical quality attributes and the associated process parameters establishes the foundation for in-process control and continuous quality assurance.
- Prescriptive analytics – These emerging capabilities include digital twins to simulate process scenarios before changes are implemented, as well as adaptive setpoint control and autonomous fault detection and mitigation, informed by historical and real-time data.
- Module Type Package (MTP) standard – A new standard is being developed to define a common interface for plug-and-play communication between process modules and higher-level systems. MTP simplifies the integration of modular equipment into plant-wide orchestration platforms, reducing custom engineering and accelerating deployment.
Why Integration Is the Silent Bottleneck
Modern biomanufacturing environments require digital systems that can integrate reliably and flexibly across multiple layers of operation. However, as systems become more interconnected — and control logic spans multiple operations and vendors — integration can quickly become a critical bottleneck.
An integration-ready digital ecosystem helps manufacturers future-proof operations, avoid delays, and reduce costly validation cycles. Users of the Sartorius platform have reported up to a 60% reduction in integration time, along with faster validation, easier cross-site deployment, and improved process robustness. This is driven by:
- Standard protocols (e.g., OPC UA) for efficient cross-platform communication
- Modular architecture supporting stepwise deployment — from single-step automation to full orchestration, analytics, and MES integration
- Validated process templates and automation libraries that reduce engineering effort and project risk.
The Business Impact: Beyond Efficiency
A robust digital infrastructure is fundamental to the performance of a next-generation facility. When combined with process intensification strategies, a comprehensive and modular digital platform drives higher productivity by contributing to lower cost of goods, reduced footprint, and higher throughput. Advanced tools also drive better cross-site standardization, smoother tech transfers, and regulatory confidence.
If you’re exploring process intensification — or scaling an intensified process — start building a digital foundation designed to support your journey.
To learn more about the digital ecosystem that enables process intensification, please read our whitepaper Digital Automation and Analytics: Enabling the Future of Intensified Biomanufacturing.
